Globus Medical Inc
NYSE:GMED
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
US |
Globus Medical Inc
NYSE:GMED
|
8.7B USD | 47.9 | ||
US |
Abbott Laboratories
NYSE:ABT
|
182.2B USD | 28.5 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
137.2B USD | 71 | ||
US |
Stryker Corp
NYSE:SYK
|
125.9B USD | 29.9 | ||
IE |
Medtronic PLC
NYSE:MDT
|
110.1B USD | 19.7 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
108.3B USD | 45.6 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.1B USD | 39.5 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.7B EUR | 31.3 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
52.2B USD | 29 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.5B CNY | 27.8 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
50.3B USD | 76.6 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.